Xylyx Bio, Inspirex Lung, FDA Orphan Drug Designation, NIH SBIR Grant, lung transplantation, regenerative medicine, bioengineered lung graft, organ repair, xenogeneic cross-circulation

Brooklyn, New York, U.S., October 20, 2026 Xylyx Bio, Inc. has received U.S. Food and Drug Administration (FDA) Orphan...